Immunex

Immunex Corporation, founded in 1981 and based in Seattle, Washington, specializes in the development, manufacturing, and marketing of therapeutic products targeting cancer, infectious diseases, and autoimmune disorders. The company's slogan "Pioneering therapeutic advancements for cancer, infectious diseases, and autoimmune disorders" reflects its commitment to innovation in the Biotechnology, Health Care, and Manufacturing industries. With key products including Enbrel for rheumatoid arthritis, Novantrone for leukemia and prostate cancer-associated pain, and Leukine for bone marrow transplant patients, Immunex has established a strong presence in the market. Notably, the company received a Venture Round investment from New Enterprise Associates in January 1992. The strategic alliance with American Home Products further underscores Immunex's potential for growth and expansion. It's worth mentioning that as of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc. This acquisition signifies the recognition of Immunex's value and potential for long-term success in the industry.